Medication in the last days of life for motor neuron disease/amyotrophic lateral sclerosis.

@article{Oliver2010MedicationIT,
  title={Medication in the last days of life for motor neuron disease/amyotrophic lateral sclerosis.},
  author={David Oliver and Colin F Campbell and Tony O'brien and Richard Sloan and Nigel Sykes and Carol Tallon and Jane Taylor-Horan and Mayen Udoma},
  journal={Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases},
  year={2010},
  volume={11 6},
  pages={
          562-4
        }
}

• David Oliver, Colin F Campbell, +5 authors Mayen Udoma
• Published 2010 in
  Amyotrophic lateral sclerosis : official…
• DOI:10.3109/17482968.2010.493203

Our objective was to study the use of opioid and other medication at the end of life for patients with ALS/MND under specialist palliative care. A retrospective study looked at the medication received by 62 patients with MND/ALS in the last 72 h of life in six hospices in the UK and Ireland. Medication is widely used in the last 24 h of life, and use of the parenteral route increases as death approaches. We found that the doses of opioids and other medication do not increase appreciably during… CONTINUE READING

Save to Library

Create Alert

Cite

View on PubMed